DK200500028A - Preparation for preventing or treating calcium deficiency conditions in mammals - Google Patents

Preparation for preventing or treating calcium deficiency conditions in mammals Download PDF

Info

Publication number
DK200500028A
DK200500028A DK200500028A DKPA200500028A DK200500028A DK 200500028 A DK200500028 A DK 200500028A DK 200500028 A DK200500028 A DK 200500028A DK PA200500028 A DKPA200500028 A DK PA200500028A DK 200500028 A DK200500028 A DK 200500028A
Authority
DK
Denmark
Prior art keywords
composition according
calcium
composition
weight
proportion
Prior art date
Application number
DK200500028A
Other languages
English (en)
Inventor
Hansen Richard Brinch
Original Assignee
Hansen Richard Brinch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansen Richard Brinch filed Critical Hansen Richard Brinch
Priority to DK200500028A priority Critical patent/DK200500028A/da
Priority to EP06700159.4A priority patent/EP1838292B1/en
Priority to ES06700159.4T priority patent/ES2605017T3/es
Priority to US11/813,459 priority patent/US9393196B2/en
Priority to CA002593394A priority patent/CA2593394A1/en
Priority to PCT/DK2006/000010 priority patent/WO2006072252A1/en
Priority to DK06700159.4T priority patent/DK1838292T3/da
Publication of DK200500028A publication Critical patent/DK200500028A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009Sachets, pouches characterised by the material or function of the envelope
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Claims (15)

1. Præparat, der omfatter en calciumkilde til forebyggelse og/eller behandling af calciummangel hos pattedyr, kendetegnet ved, at præparatet i alt væsentligt er tørt og er indesluttet i et i det væsentlige vandopløseligt, -dispergerbart eller -nedbrydeligt hylster, der hovedsageligt udgøres af cellulosemateriale eller gelatineret stivelsesmateriale.
2. Præparat ifølge krav 1, hvor cellulosematerialet er karton, pap, massivpap eller limet pap, som eventuelt kan være limet med en vandopløselig spiselig lim.
3. Præparat ifølge krav 1 eller 2, hvor hylstret er forsynet med mindst én svækkelseslinje, som hurtigt vil blive brudt af et dyrs mavesaft eller vomvæske.
4. Præparat ifølge et hvilket som helst af de foregående krav, hvor hylstret har form som et cylindrisk rør, der er lukket i begge ender med en hætte eller en skive af cellulose eller gelatineret stivelsesmateriale.
5. Præparat ifølge krav 4 hvor randen i den ene ende af det cylindriske rør er bertlet eller bukket indad for at sikre en afrundet yderende og en indvendig vulst eller afsats, på hvilken en indvendig rund endeskive ligger an mod, mens den anden ende af det cylindriske rør er lukket af en rund skive, som er indsat i rørets lysning og fastgjort heri med voks, paraffin eller vandopløselig lim.
6. Præparat ifølge krav 4 eller 5, hvor røret er forsynet med mindst en svækkelseslinje på tværs af røret langs omkredsen i form af en valset eller skåret rille eller en række af perforeringspunkter eller smalle spalter.
7. Præparat ifølge et hvilket som helst af de foregående krav, hvor præparatet, der indeholder calciumkilden, foreligger i pulverform.
8. Præparat ifølge krav 9, hvor det pulverformige præparat foreligger i kompakt eller komprimeret form.
9. Præparat ifølge krav 7 eller 8, hvor calciumkilden omfatter en blanding af calciumchlorid og calciumpropionat
10. Præparat ifølge krav 9, hvor andelen af calciumchlorid udgør 10-99 vægt-%, og andelen af calciumpropionat udgør 90-1 vægt-%, af den samlede blanding af calciumchlorid og calciumpropionat.
11. Præparat ifølge krav 10, hvor andelen af calciumchlorid udgør 50-95 vægt-%, fortrinsvis 70-90 vægt-%, og andelen af calciumpropionat udgør 50-5 vægt-%, fortrinsvis 30-10 vægt-%, af den samlede blanding af calciumchlorid og calciumpropionat.
12. Præparat ifølge et hvilket som helst af de foregående krav, hvor præparatet yderligere indeholder en magnesiumforbindelse.
13. Præparat ifølge krav 12, hvor magnesiumforbindelsen er udvalgt blandt MgO og MgS04.
14. Præparat ifølge et hvilket som helst af de foregående krav, hvor præparatet yderligere indeholder vitamin D3.
15. Anvendelse af præparatet ifølge et hvilket som helst af de foregående krav til forebyggelse og/eller behandling af mælkefeber (Parturient Paresis) hos pattedyr, specielt kvæg, navnlig malkekøer.
DK200500028A 2005-01-07 2005-01-07 Preparation for preventing or treating calcium deficiency conditions in mammals DK200500028A (da)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DK200500028A DK200500028A (da) 2005-01-07 2005-01-07 Preparation for preventing or treating calcium deficiency conditions in mammals
EP06700159.4A EP1838292B1 (en) 2005-01-07 2006-01-06 Preparation for preventing or treating calcium deficiency conditions in mammals
ES06700159.4T ES2605017T3 (es) 2005-01-07 2006-01-06 Preparación para prevenir o tratar afecciones por carencia de calcio en mamíferos
US11/813,459 US9393196B2 (en) 2005-01-07 2006-01-06 Preparation for preventing or treating calcium deficiency conditions in mammals
CA002593394A CA2593394A1 (en) 2005-01-07 2006-01-06 Preparation for preventing or treating calcium deficiency conditions in mammals
PCT/DK2006/000010 WO2006072252A1 (en) 2005-01-07 2006-01-06 Preparation for preventing or treating calcium deficiency conditions in mammals
DK06700159.4T DK1838292T3 (da) 2005-01-07 2006-01-06 Præparat til forebyggelse eller behandling af kalciummangel i pattedyr

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK200500028A DK200500028A (da) 2005-01-07 2005-01-07 Preparation for preventing or treating calcium deficiency conditions in mammals

Publications (1)

Publication Number Publication Date
DK200500028A true DK200500028A (da) 2006-08-11

Family

ID=36647426

Family Applications (2)

Application Number Title Priority Date Filing Date
DK200500028A DK200500028A (da) 2005-01-07 2005-01-07 Preparation for preventing or treating calcium deficiency conditions in mammals
DK06700159.4T DK1838292T3 (da) 2005-01-07 2006-01-06 Præparat til forebyggelse eller behandling af kalciummangel i pattedyr

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06700159.4T DK1838292T3 (da) 2005-01-07 2006-01-06 Præparat til forebyggelse eller behandling af kalciummangel i pattedyr

Country Status (6)

Country Link
US (1) US9393196B2 (da)
EP (1) EP1838292B1 (da)
CA (1) CA2593394A1 (da)
DK (2) DK200500028A (da)
ES (1) ES2605017T3 (da)
WO (1) WO2006072252A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070190116A1 (en) * 2005-11-01 2007-08-16 Rigel Technology Corporation Solid calcium bolus product with quick dissolution
CN101516210A (zh) * 2006-09-14 2009-08-26 帝斯曼知识产权资产管理有限公司 含有一种或多种维生素d3化合物和一种或多种镁盐的食物补剂组合物
DK2301595T3 (da) * 2009-09-23 2014-04-07 Dentsply Ih Ab Gennemskylleligt kateter og fremgangsmåde til fremstilling af sådan et kateter
EP3241544A1 (en) * 2016-05-06 2017-11-08 Vetcare Oy Cellulose cartridge
GB2551363A (en) * 2016-06-15 2017-12-20 Animax Ltd Multi-component bolus
US10342824B2 (en) 2017-07-17 2019-07-09 Dr. Marlowe's Weight Loss Institute, P.L.L.C. Supplement for treating side effects of medications which cause metabolic acidosis
US20210353668A1 (en) * 2018-09-28 2021-11-18 Performanat Gmbh Calcium composition
EP3628312A1 (en) 2018-09-28 2020-04-01 PerformaNat GmbH Calcium preparation
DE102019119651A1 (de) * 2019-07-19 2021-01-21 Ludwig Gülker Ergänzungsfuttermittel zur Vermeidung von Stoffwechselstörungen bei Nutztieren

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346077A (en) * 1980-03-21 1982-08-24 Agway, Inc. Method for reducing incidence of periparturient disorders in cows
JPS6032714A (ja) * 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
US4621763A (en) * 1985-09-12 1986-11-11 International Paper Company Container end construction
SE461567B (sv) * 1987-05-06 1990-03-05 Anders Kjellstroem Kapsel av pressad cellulosa foer tillfoersel av flytande eller fasta substanser till vaextaetare
US4931290A (en) * 1988-09-23 1990-06-05 Domain, Inc. Milk fever prophylactic treatment and composition
ATE87483T1 (de) 1988-12-23 1993-04-15 Boehringer Ingelheim Agrovet Kalziumchlorid enthaltende zubereitung bei der vorbeugung und behandlung von hypocalcaemie bei wiederkaeuern.
US5395622A (en) * 1988-12-23 1995-03-07 Boehringer Ingelheim Agrovet A/S Calcium chloride containing preparation for the prevention or the treatment of hypocalcemia in ruminants
US5007579A (en) * 1990-08-29 1991-04-16 Thomas Jr Henry H Fiberboard cylindrical container with spirally wound tubular body and closure therefor
DK106293D0 (da) 1993-09-22 1993-09-22 Joergen Rasmussen Kapsel til indbringning af laegemidler i kreaturmaver
US5560920A (en) * 1995-04-07 1996-10-01 The United States Of America, As Represented By The Secretary Of Agriculture Calcium formulations for prevention of parturient hypocalcemia
US5958464A (en) * 1996-02-08 1999-09-28 Register; Jack W. Veterinary pharmaceutical composition
EP0919228A4 (en) * 1996-08-02 2001-12-12 Hisamitsu Pharmaceutical Co CAPSULES FOR ORAL PREPARATIONS AND CAPSULE PREPARATIONS FOR ORAL ADMINISTRATION
SE9700868D0 (sv) 1997-03-10 1997-03-10 Kemira Kemi Ab Kalciumkomposition

Also Published As

Publication number Publication date
US20080292666A1 (en) 2008-11-27
CA2593394A1 (en) 2006-07-13
US9393196B2 (en) 2016-07-19
DK1838292T3 (da) 2016-12-19
EP1838292B1 (en) 2016-08-31
ES2605017T3 (es) 2017-03-10
WO2006072252A1 (en) 2006-07-13
EP1838292A1 (en) 2007-10-03
EP1838292A4 (en) 2012-09-26

Similar Documents

Publication Publication Date Title
DK200500028A (da) Preparation for preventing or treating calcium deficiency conditions in mammals
ATE378376T1 (de) Polyvinylalkohol-zusammensetzungen
Pandurangan et al. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2
Rabeh et al. Hepatoprotective effect of dill (Anethum graveolens L.) and fennel (Foeniculum vulgare) oil on hepatotoxic rats
Pankaj et al. The effects of alcoholic extract of Arjuna (Terminalia arjuna Wight & Arn.) bark on stability of clarified butterfat
Kosala et al. In vitro and in vivo anti-inflammatory activities of Coptosapelta flavescens Korth Root’s methanol extract
ES2422430T3 (es) Cápsula de aromas para una mejor entrega de aroma en cigarrillos
BR0013045B1 (pt) conjunto de rolos cortadores de caule de milho para uma mÁquina colheitadeira.
Gao et al. Impact of epigenetic dietary components on cancer through histone modifications
US20180027869A1 (en) Non-tobacco non-thc industrial hemp fiber smoking article
Islam et al. Potential immunomodulatory effects of non-dialyzable materials of cranberry extract in poultry production
Pradhan et al. Epigenetic dietary interventions for prevention of cancer
Wangcharoen et al. Antioxidant activity changes during hot-air drying of Moringa oleifera leaves.
Ryu et al. Aged red garlic extract suppresses nitric oxide production in lipopolysaccharide-treated RAW 264.7 macrophages through inhibition of NF-κ B
Bubols et al. Nitric oxide and reactive species are modulated in the polyphenol‐induced ductus arteriosus constriction in pregnant sheep
Fukutake et al. Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats
Beer et al. Effects of 1, 8-cineole on the activity of cyclooxygenase and cyclooxygenase 1 and cyclooxygenase 2 isoforms
AR007165A1 (es) Composición farmacéutica para uso oral que contiene diclofenac.
WO2010018802A1 (ja) ペルオキシダーゼを用いた中性下の消臭組成物
US20220304371A1 (en) Filters and elongated members formed of palm paper and having a flavor capsule
JP2005508347A5 (da)
MX2010005148A (es) Agentes saborizantes.
Ghazali et al. Protective effects of pterostilbene against cardiac oxidative stressand dysfunctionin nicotine-induced cardiac injury rat model
RU2292825C1 (ru) Изделие для борьбы с конденсатом в канале мундштука курительной трубки
Sakai et al. Identification of Anogeissus latifolia Wallich and analysis of refined gum ghatti

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons

Effective date: 20170212